56708-70-4

Basic information

• Product Name: 2-[2-(4-bromophenyl)-2-oxoethyl]isoquinolinium
• Synonyms: 2-[2-(4-Bromophenyl)-2-oxoethyl]isoquinolinium; 2-[2-(4-Bromo-phenyl)-2-oxo-ethyl]-isoquinolinium; Isoquinolinium, 2-[2-(4-bromophenyl)-2-oxoethyl]-
• CAS NO: 56708-70-4
• Molecular Formula: Br*C₁₇H₁₃BrNO
• Molecular Weight: 327.1947
• Mol File: 56708-70-4.mol
• Article Data: 11

Chemical Properties

• CAS DataBase Reference: 2-[2-(4-bromophenyl)-2-oxoethyl]isoquinolinium(CAS DataBase Reference)
• NIST Chemistry Reference: 2-[2-(4-bromophenyl)-2-oxoethyl]isoquinolinium(56708-70-4)
• EPA Substance Registry System: 2-[2-(4-bromophenyl)-2-oxoethyl]isoquinolinium(56708-70-4)

Safety Data

• Hazardous Substances Data: 56708-70-4(Hazardous Substances Data)

Usage

Molecular structure

Contains an isoquinolinium core and a 4-bromophenyl group.

Usage

Often used as a reactant or reagent in various synthetic pathways in the field of organic chemistry.

Pharmacological and biological activities

Exhibits potential activities making it an important target for medicinal chemistry research.

Unique structure and properties

Useful in the development of new materials and technologies.

Handling precautions

Should be handled with caution due to potential reactivity and toxicity.

Versatility

Has a wide range of potential applications in various scientific and industrial fields.

Upstream product

• 119-65-3 isoquinoline 
• 99-73-0 para-bromophenacyl bromide 

Downstream Products

• 148067-09-8 2-(4-bromo-phenacyl)-isoquinolinium; betaine 
• 74918-94-8 2,6‐bis(4‐bromophenyl)‐4‐phenylpyridine 
• 74918-92-6 2-(4-Bromo-phenyl)-4,6-di-p-tolyl-pyridine 
• 74918-93-7 2-(4-Bromo-phenyl)-4,6-bis-(4-chloro-phenyl)-pyridine 
• 74918-95-9 4-Benzo[1,3]dioxol-5-yl-2-(4-bromo-phenyl)-6-(4-chloro-phenyl)-pyridine 
• 61001-06-7 2-(4-bromophenyl)imidazo<2,1-a>isoquinoline 
• 87773-09-9 4-Imidazo[2,1-a]isoquinolin-2-yl-benzonitrile 
• 1047654-96-5 (Z)-3-(4-bromophenyl)-2-(isoquinolinium-2-yl)-3-oxo-1-[3-(trifluoromethyl)phenylamino]prop-1-ene-1-thiolate 
• 1047655-05-9 (Z)-3-(4-bromophenyl)-1-(4-cyanophenylamino)-2-(isoquinolinium-2-yl)-3-oxoprop-1-ene-1-thiolate 
• 1047654-94-3 (Z)-3-(4-bromophenyl)-2-(isoquinolinium-2-yl)-1-(4-methoxyphenylamino)-3-oxoprop-1-ene-1-thiolate 
• 1047654-93-2 (Z)-3-(4-bromophenyl)-2-(isoquinolinium-2-yl)-1-(4-nitrophenylamino)-3-oxoprop-1-ene-1-thiolate 
• 1187763-97-8 dimethyl 3-(4-bromobenzoyl)benzo[g]indolizine-1,2-dicarboxylate 
• 618070-09-0 diethyl 3-(4-bromobenzoyl)pyrrolo[2,1-a]isoquinoline-1,2-dicarboxylate 
• 853319-35-4 diisopropyl 3-(4-bromobenzoyl)pyrrolo[2,1-a]isoquinoline-1,2-dicarboxylate 

Relevant articles and documents

Synthesis and biological screening of new cyano-substituted pyrrole fused (Iso)quinoline derivatives

Several new cyano-substituted derivatives with pyrrolo[1,2-a]quinoline and pyrrolo[2,1a]isoquinoline scaffolds were synthesized by the [3 + 2] cycloaddition of (iso)quinolinium ylides to fumaronitrile. The cycloimmonium ylides reacted in situ as 1,3-dipol

DABCO-catalyzed multi-component domino reactions for the one-pot efficient synthesis of diverse and densely functionalized benzofurans in water

An efficient, three-component strategy for the improved synthesis of a pharmaceutically interesting diverse kind of multi-functionalized benzofurans via one-pot two-step domino protocol with high diastereoselectivity in excellent yields has been established. The synthesis was achieved by reacting phenacyl bromides, N-heterocycles, aromatic aldehydes, and cyclic 1,3-dicarbonyl compounds in the presence of a catalytic amount of DABCO (1,4-diazabicyclo[2.2.2]octane) as an inexpensive, impressive, and readily available catalyst in water under reflux. In this process in total three new bonds (two C–C and one C–O) form in one pot. Short reaction time, excellent yields, no chromatographic purification, and evasion of environmentally hazardous or toxic catalysts and organic solvents in the entire reaction process may make this protocol very useful for academia and industry.

Synthesis and biological evaluation of some new indolizine derivatives as antitumoral agents

A new series of indolizine derivatives were synthesized and screened for the antiproliferative potential against NCI 60 tumor cell line panel. The results of the study revealed a selective and good antitumor growth inhibitory activity against SNB-75 CNS c